News tips from ACS Chemical Biology

Highlights from the American Chemical Society journal, ACS Chemical Biology, are now available. Below is a link to the February 2007 edition.

In the current issue we learn:

• A new potential treatment for cancer might be developed by linking proteins found on the outside of a cell to proteins that help activate the immune system. The linker is a small molecule that can bind to both the immune system molecules and the cell surface molecules

• About a new way to find binding partners of phoshorylated signaling proteins using high-throughput screening

• How to make a new type of drug that stops cancer cells from growing in the lab. This drug, called a pyropyranone, is made partially by bacteria and then finished by humans in the lab.

• How some bacteria stop other bacteria from communicating. Bacteria secrete chemicals to communicate with each other, and here we learn that one type of bacteria can internalize the signals from other bacteria which halt their game of telephone tag.

http://www.eurekalert.org/jrnls/acs/index.php?page=chemicalbiology.

Journalists can arrange access of any of the articles featured in ACS Chemical Biology by sending an e-mail to newsroom@acs.org or by contacting m_woods@acs.org.

ACS Chemical Biology is a monthly journal exploring cellular function from both chemical and biological perspectives. In addition to research papers and reviews, the journal also publishes Spotlights of current research in chemical biology, Profiles of experts in the field, and Points of View from leading scientists. The journal web site is updated weekly with new content, and it features a WIKI and Ask the Expert.

The American Chemical Society – the world’s largest scientific society – is a nonprofit organization chartered by the U.S. Congress and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

---

---